Recently, an additional function for JMJD6 as a tyrosine kinase targeting the Y39 tyrosine of the histone variant H2A.X has been reported in triple negative breast cancer cell lines overexpressing JMJD6 [22]. Here, JMJD6 is linked to triple-negative breast carcinoma.